No sales today

Good to see no cheap selling today.

Next week we see the quarterly and that should indicate whether or not things are still on track after the recent CR and takeover fiascos. From the company feedback a few weeks ago I expect we will continue to see good market penetration by Ferriscan. They said that May was our best ever month and up 20% on last year's May. Hopefully June will continue that growth. With our continually increasing Ferriscan penetration we will be putting froward Hepafat as a company well known to the market which should help it a lot once it is under way.

We are already cash flow positive and would need about $1 million profit for the year before a dividend at 1 tenth of a cent per share could be considered. That would be $1000 on 1 million shares. Perhaps August 2015? But once Hepafat is in full swing it would increase rapidly. Note that growth at 20% pa doubles revenue every 3.5 years, which means that after deducting expenses (which don't increase near that rapidly) the profit growth will be very much greater than 20% pa initially, but easing off as the underlying expenses have less effect proportionately.